Andrea Hartzark, MD

Joseph Presti, MD - Oncologist

Kaiser East Bay Oakland

Target Audience: 

Oncologists, Urologists

Educational Objectives:

As a result of this session, participants will be able to:

  1. Define when to consider chemotherapy for metastatic hormone sensitive prostate cancer.
  1. Define when to consider perioperative chemotherapy for invasive bladder cancer.
  1. Define when to consider palliative care referral for advanced cancers.

Statement of Disclosure:

Kaiser Foundation Hospital Oakland/Richmond has determined that the speakers and the planning committee for this program do not have affiliations with any corporate organizations (commercial interests) that may constitute a conflict of interest with this program.  Kaiser Foundation Hospital Oakland/Richmond does not endorse any brand name products.

Kaiser Foundation Hospital Oakland/Richmond is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.

Kaiser Foundation Hospital Oakland/Richmond designates this live activity for a maximum of 1.0 AMA PRA Category 1 credit(s)TM.. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Nurses may report up to a maximum of 1.0 hours of credit towards the continuing medical education requirements for license renewal by the California Board of Registered Nurses.                                                                                  



Session date: 
03/11/2020 - 12:30pm to 1:30pm PDT
Oakland Medical Center
3600 Broadway
Oakland, CA 94611
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Geriatrics
  • 1.00 Pain/EOL

Please login or register to take this course.
CME Office: